Sequans (SQNS) Q3 2026 Earnings Call Transcript

Sequans reported Q3 2026 revenue of $9.1 million, up 21.9% sequentially and 182.8% year over year; product revenue more than quadrupled year over year, and gross margin rose to 33.0% from 25.3% a year earlier. Q4 revenue guidance is $9.5 million–$11 million, excluding major licensing contributions; cash and short-term deposits totaled about $39.8 million at Sept. 30 after the company sold its remaining 314 Bitcoin for $24.6 million. Management cited volatile memory costs and TSMC capacity allocation for mature nodes in 2027 as risks, while targeting more than $180 million of its design-win pipeline in mass production by year-end.

Analysis

SQNS’s reported near-breakeven headline overstates the operating inflection: removing the $6.2m digital-asset gain from the $1.0m operating loss implies an underlying quarterly operating loss of roughly $7.2m. At current revenue, a 33% gross margin produces only about $3m of gross profit against $10.3m of operating expense. The core question is therefore not demand visibility, but whether product mix and cost pass-through can lift margins fast enough to close a still-material gap. Management’s >50% margin ambition is conditional on a better chip/module mix, higher-margin RF and licensing, and lower component pressure—not yet demonstrated in results.

The $300m design-win pool and >$180m targeted in mass production are three-year potential revenue, not contracted annual sales. Treat book-to-bill and backlog as leading indicators, while tracking shipments, customer concentration, and conversion cadence. Near term, memory repricing can compress margins before customer price resets; in 2027, mature-node wafer allocation at TSMC could cap upside even if demand converts. Conversely, tighter supply may support industry pricing, but SQNS’s ability to secure wafers and pass through costs is the company-specific swing factor. Cash provides a buffer, but the $5.9m quarterly burn implies limited room for prolonged execution slippage without faster cash generation.

Contrarian view: the clean balance sheet and growth headline may invite a rerating before earnings quality is proven. Licensing is upside, not a base-case bridge: signing a deal does not guarantee same-quarter revenue recognition. The 5G eRedCap opportunity is structurally interesting but remains a 2028 revenue prospect; avoid paying today for that transition as if it were near-term. No valuation or share-price context is supplied, so sizing should wait for those checks.

Key Decisions for Investors

• SQNS: Treat as a high-volatility, catalyst-driven watch rather than chase the earnings headline. Consider a small long only after reviewing current valuation/liquidity and seeing another quarter of product-led growth with gross margin holding or improving; the thesis is falsified by slowing product shipments or sustained margin deterioration.
• For the next 1–3 months, monitor Q4 revenue against the $9.5m–$11m guide, gross margin, and licensing revenue actually recognized—not merely signed. A miss on product revenue or a sharp margin decline would outweigh pipeline commentary.
• For 2027, track TSMC wafer allocation, SQNS secured wafer volumes, memory cost pass-through timing, and the share of higher-margin chip/RF and licensing revenue. Escalate the thesis only if production conversion and margin improvement appear together.
• Do not use the three-year pipeline as a near-term revenue run-rate assumption. Verify customer concentration, backlog cancellation terms, and cash-burn trajectory in filings and subsequent calls; a sustained burn near the Q3 rate without improving gross profit would weaken the balance-sheet cushion.